MML Investors Services
TEVA icon

MML Investors Services’s Teva Pharmaceuticals TEVA Stock Holding History

MML Investors Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Buy
79,705
+12,927
+19% +$431K 0.01% 1360
2026
Q1 		$2.01M Buy
66,778
+18,474
+38% +$594K 0.01% 1315
2025
Q4 		$1.51M Buy
48,304
+6,328
+15% +$156K ﹤0.01% 1540
2025
Q3 		$848K Sell
41,976
-878
-2% -$15.4K ﹤0.01% 1847
2025
Q2 		$718K Buy
42,854
+6,377
+17% +$103K ﹤0.01% 1861
2025
Q1 		$561K Buy
36,477
+388
+1% +$6.93K ﹤0.01% 1916
2024
Q4 		$795K Sell
36,089
-440
-1% -$8.01K ﹤0.01% 1648
2024
Q3 		$658K Sell
36,529
-5,710
-14% -$99.9K ﹤0.01% 1697
2024
Q2 		$686K Sell
42,239
-795
-2% -$12.2K ﹤0.01% 1600
2024
Q1 		$607K Buy
43,034
+3,115
+8% +$39.3K ﹤0.01% 1695
2023
Q4 		$417K Buy
39,919
+4,254
+12% +$39.7K ﹤0.01% 1857
2023
Q3 		$364K Sell
35,665
-848
-2% -$7.9K ﹤0.01% 1814
2023
Q2 		$275K Buy
36,513
+6,006
+20% +$48.7K ﹤0.01% 1982
2023
Q1 		$270K Sell
30,507
-1,354
-4% -$13.4K ﹤0.01% 1739
2022
Q4 		$291K Sell
31,861
-1,381
-4% -$12.1K ﹤0.01% 1798
2022
Q3 		$268K Buy
33,242
+1,536
+5% +$13.6K ﹤0.01% 1753
2022
Q2 		$238K Sell
31,706
-3,615
-10% -$31.5K ﹤0.01% 1809
2022
Q1 		$332K Sell
35,321
-1,475
-4% -$12.3K ﹤0.01% 1660
2021
Q4 		$295K Sell
36,796
-4,481
-11% -$40.4K ﹤0.01% 1711
2021
Q3 		$402K Buy
41,277
+7,564
+22% +$70.8K ﹤0.01% 1471
2021
Q2 		$334K Sell
33,713
-15,976
-32% -$169K ﹤0.01% 1546
2021
Q1 		$573K Sell
49,689
-4,929
-9% -$56.5K 0.01% 1196
2020
Q4 		$527K Sell
54,618
-13,984
-20% -$134K 0.01% 1132
2020
Q3 		$618K Sell
68,602
-11,585
-14% -$123K 0.01% 948
2020
Q2 		$989K Sell
80,187
-5,935
-7% -$67.1K 0.01% 716
2020
Q1 		$773K Buy
86,122
+1,911
+2% +$19.6K 0.01% 697
2019
Q4 		$825K Sell
84,211
-4,087
-5% -$36.5K 0.01% 793
2019
Q3 		$607K Sell
88,298
-24,240
-22% -$186K 0.01% 874
2019
Q2 		$1.04M Sell
112,538
-8,139
-7% -$98.1K 0.01% 705
2019
Q1 		$1.89M Buy
120,677
+621
+0.5% +$11K 0.03% 480
2018
Q4 		$1.85M Sell
120,056
-3,804
-3% -$78K 0.03% 440
2018
Q3 		$2.67M Buy
123,860
+30,163
+32% +$700K 0.05% 359
2018
Q2 		$2.28M Sell
93,697
-1,244
-1% -$25.4K 0.05% 324
2018
Q1 		$1.62M Sell
94,941
-9,576
-9% -$187K 0.03% 400
2017
Q4 		$1.98M Buy
104,517
+12,671
+14% +$191K 0.04% 356
2017
Q3 		$1.62M Buy
91,846
+58,191
+173% +$1.31M 0.03% 387
2017
Q2 		$1.12M Buy
33,655
+3,236
+11% +$100K 0.02% 474
2017
Q1 		$976K Buy
+30,419
New +$1.04M 0.02% 282

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

MML Investors Services's TEVA Position: Q2 2026 in Review

MML Investors Services increased its Teva Pharmaceuticals (TEVA) stake by 19% in Q2 2026, buying an estimated $431K and bringing the position to 79,705 shares worth $2.7M. The position accounts for 0.01% of the portfolio, ranked #1360.

MML Investors Services first reported a position in TEVA in Q1 2017 and has held it in 38 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • MML Investors Services held 79,705 shares of Teva Pharmaceuticals worth $2.7M as of Q2 2026.
  • MML Investors Services bought 12,927 Teva Pharmaceuticals shares in Q2 2026, an estimated $431K.
  • Teva Pharmaceuticals made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1360 holding.
  • MML Investors Services first reported a position in Teva Pharmaceuticals in Q1 2017 and has held it in 38 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.